Anti-CCR4 antibodies and methods of use therefor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6488930
SERIAL NO

09231759

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 4 (CCR4) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR4 with a ligand thereof, and to use of the antibodies and fragments in research, therapeutic, prophylactic and diagnostic methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 5410045 ?5410045

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andrew, David Waltham, MA 8 52
Ruffing, Nancy Somerville, MA 1 44
Wu, Lijun Reading, MA 59 303

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation